ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 008

Body Mass Index, Neighborhood Opportunity, and Outcomes of Childhood-Onset Lupus

Adriana Gordon De Jesús1, Ankana Daga2 and Joyce Chang2, 1Boston Children's Hospital, MA, 2Boston Children's Hospital, Boston, MA

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, March 19, 2026

Title: Posters: Clinical and Therapeutic Aspects I

Session Time: 6:00PM-7:00PM

Background/Purpose: The interplay between body mass index (BMI) and disease outcomes in childhood-onset systemic lupus erythematosus (cSLE) has not been characterized. Neighborhood factors drive health disparities and may affect both BMI trajectories and cSLE outcomes. We examined associations of area-level factors captured by the Child Opportunity Index (COI) with BMI changes over time and subsequent cSLE outcomes.

Methods: BMI trajectories of children with incident cSLE followed for ≥1 year at a tertiary center (2000-2014 inclusive) were identified using group-based trajectory modeling. We included children with incident SLE that met criteria for at least one of 1997 ACR, SLICC, or 2019 ACR-EULAR SLE classification; 93% of them met ACR-EULAR criteria. Predictors of trajectory membership, including COI v3.0 level (very low/low, moderate/high, very high), and longitudinal outcomes, SLE disease activity index (SLEDAI-2K) and urine protein: creatinine ratio (UPC), were evaluated using multinomial logistic and mixed-effects models, respectively, adjusted for baseline factors.

Results: Among 163 children with cSLE (1,559 total visits), 46% lived in low/very low COI areas, 45% were publicly insured, 19% were Black and 21% Hispanic; most Hispanic (85%) and Black (74%) patients lived in low/very low COI areas. Overall, 12% were underweight and 26% were overweight/obese at cSLE diagnosis. Three BMI trajectory groups: “High”, “Intermediate”, and “Low” were identified (Fig. 1). Predictors of group membership are shown in Table 1. Younger age of onset and residence in moderate/high vs. very high COI areas increased the likelihood of low BMI trajectory, with a similar non-significant trend for low/very low COI. More Black and publicly insured patients tended toward the high BMI group (Table 1). SLEDAI-2K scores decreased over time across all groups, but those living in moderate/high and low/very low COI areas had higher mean SLEDAI compared to very high COI areas (Fig. 2A). This association persisted after adjustment for BMI category, although underweight status was independently associated with higher disease activity vs. normal weight (Fig. 2B). Among 72 patients with lupus nephritis, UPC decreased over time, with a trend toward higher UPC in lower COI areas (Fig. 2C). BMI category was not associated with UPC over time (Fig. 2D).

Conclusion: Lower neighborhood opportunity was associated with low BMI trajectories and higher disease activity in children with cSLE, with a trend toward greater proteinuria among those from disadvantaged areas. These findings suggest that social and environmental context may influence disease severity and recovery in cSLE and warrant validation in larger, multi-center studies.

Table 1. Predictors of BMI trajectory group membership.Supporting image 1Multinomial logistic regression estimates of relative risk ratios (RRR) representing the likelihood of belonging to either the “Low” or “High” BMI trajectory group compared with the reference group (“Intermediate” BMI). Models include baseline COI level, age, sex, racial ethnic category, and insurance. Language preference, baseline prednisone dose, and baseline SLEDAI-2K were tested in the models and did not meet criteria for retention (p-value < 0.2 or evidence of confounding as determined by a change in coefficients of interest by at least 15%).

Figure 1. BMI trajectories in Pediatric Lupus patients. Supporting image 2Longitudinal BMI trajectories (BMI z-score for age and sex) among individuals with cSLE (n=163) derived using group-based trajectory modeling. Three groups were identified: low BMI (consistently lower BMI across visits), normal BMI (intermediate BMI), and high BMI (consistently higher BMI).

Figure 2. Predicted disease activity and proteinuria by COI and BMI category.Supporting image 3A. Model-predicted SLEDAI-2K scores over time stratified by COI group, adjusted for age, sex, insurance, race and BMI. B. Model-predicted SLEDAI-2K scores over time stratified by BMI category, adjusted for age, sex, insurance, race and COI. C. Model-predicted urine protein-to-creatinine ratio (UPC) scores over time by COI group. D. Model-predicted urine protein-to-creatinine ratio (UPC) scores over time by BMI category, adjusted for age, sex, insurance, race and BMI. Predictions are derived from mixed-effects linear regression models with random intercept and random slope accounting for repeated measures within patients. Lines represent model-estimated marginal means; capped spikes indicate 95% confidence intervals. Asterisk represents statistically significant results (p-value < 0.05, 2-tailed).


Disclosures: A. Gordon De Jesús: None; A. Daga: None; J. Chang: Century Therapeutics, 2.

To cite this abstract in AMA style:

Gordon De Jesús A, Daga A, Chang J. Body Mass Index, Neighborhood Opportunity, and Outcomes of Childhood-Onset Lupus [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/body-mass-index-neighborhood-opportunity-and-outcomes-of-childhood-onset-lupus/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/body-mass-index-neighborhood-opportunity-and-outcomes-of-childhood-onset-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology